Abnormal nucleoli architecture and aggregate formation in nucleophosmin mutated acute myeloid leukaemia

Area of Science:

• Cell Biology
• Cancer Genetics
• Molecular Oncology

Background:

• Nucleophosmin (NPM1) mutations are the most frequent genetic alteration in acute myeloid leukaemia (AML).
• These mutations cause NPM1 protein mis-localization from the nucleolus to the cytoplasm.
• The nucleolus, particularly its rim, plays a critical role in cellular function and its architecture is poorly understood.

Purpose of the Study:

• To investigate the role of NPM1 in maintaining nucleoli architecture and function in AML.
• To characterize the nucleolar phenotype associated with NPM1 mutations.
• To identify potential therapeutic vulnerabilities in NPM1-mutated AML.

Main Methods:

• High-resolution imaging of nucleoli in cell lines and primary AML cells with NPM1 mutations.
• Assessment of nucleolar function using a surrogate for rRNA synthesis.
• Analysis of perinucleolar chromatin organization.
• Characterization of NPM1 mutated protein aggregates.

Main Results:

• NPM1 is essential for normal nucleoli architecture, especially the nucleoli rim integrity.
• NPM1 mutations lead to aberrant nucleoli architecture, which is reversible.
• Aberrant nucleoli are associated with increased RNA polymerase I activity and altered perinucleolar chromatin organization.
• NPM1 mutated protein forms distinct aggregates, characterized for the first time.

Conclusions:

• NPM1 mutations disrupt nucleolar organization and function, contributing to AML pathogenesis.
• The observed nucleolar abnormalities are reversible, suggesting potential therapeutic strategies.
• Understanding NPM1's role in nucleolar structure reveals novel therapeutic vulnerabilities for NPM1-mutated AML.